Name: The esc Textbook of Thrombosis (en Inglés)
Price: 3136.24 MXN
Availability: InStock
Author: De Caterina Raffaele; Moliterno David; Kristensen Steen
ISBN: 9780192869227

Envío gratis

portada The esc Textbook of Thrombosis (en Inglés)

Formato

Libro Físico

Editorial

Oxford University Press,

Autor

De Caterina Raffaele; Moliterno David; Kristensen Steen

Idioma

Inglés

Encuadernación

Tapa Dura

ISBN13

9780192869227

The esc Textbook of Thrombosis (en Inglés)

De Caterina Raffaele; Moliterno David; Kristensen Steen (Autor) · Oxford University Press, · Tapa Dura

Libro Nuevo

$ 3,136.24

$ 6,272.48

Ahorras: $ 3,136.24

50% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Viernes 24 de Mayo y el Lunes 03 de Junio.

Lo recibirás en cualquier lugar de México entre 1 y 3 días hábiles luego del envío.

Reseña del libro "The esc Textbook of Thrombosis (en Inglés)"

The ESC Textbook of Thrombosis is the third iteration of Therapeutic Advances in Thrombosis. Now a new addition to the European Society of Cardiology (ESC) publications portfolio, it is informed by the work of the ESC's Working Group on Thrombosis. Written by internationally renowned experts in the field of thrombosis, the textbook presents an up-to-date and in-depth review of all aspects of thrombosis and antithrombotic therapies. Not only does it reflect contemporary European guidelines from the ESC but also it also summarizes the latest evidence from clinical trials. Covering the topic in great detail with thirty-one chapters, the textbook is split into four sections: Pathophysiology of thrombosis, Clinical pharmacology of antithrombotic drugs, Therapeutic strategies, and Special situations. Appealing to the large community of cardiovascular healthcare specialists in Europe and across the world, the textbook is a must read for cardiologists dealing with acute and chronic coronary syndromes, atrial fibrillation, artificial heart valves and pulmonary embolism. It will also appeal to cardiac surgeons, cardiovascular researchers, and general physicians alike.